Taking the Myc out of cancer: toward therapeutic strategies to directly inhibit c-Myc.

Taking the Myc out of cancer: toward therapeutic strategies to directly inhibit c-Myc.
复制标题

DOI:
10.1186/s12943-020-01291-6
复制
发表时间:
2021-01-04
期刊:
影响因子:
37.3
通讯作者:
Mason JM
Mason JM
中科院分区:
医学1区
文献类型:
--
作者:
Madden SK;de Araujo AD;Gerhardt M;Fairlie DP;Mason JM

文献摘要

参考文献

被引文献

相似文献

c-Myc是一种转录因子,在超过70%的人类癌症中组成性和异常表达。它的直接抑制已被证明可以在小鼠中引发快速的肿瘤消退,只有轻微和完全可逆的副作用,这表明这是一种可行的治疗策略。在这里,我们重新评估了直接靶向c-Myc的挑战,评估了从目前的抑制剂中吸取的教训,并探讨了未来的策略,如Omomyc和靶向E-box结合,如何促进c-Myc抑制剂转化为临床。
c-Myc is a transcription factor that is constitutively and aberrantly expressed in over 70% of human cancers. Its direct inhibition has been shown to trigger rapid tumor regression in mice with only mild and fully reversible side effects, suggesting this to be a viable therapeutic strategy. Here we reassess the challenges of directly targeting c-Myc, evaluate lessons learned from current inhibitors, and explore how future strategies such as miniaturisation of Omomyc and targeting E-box binding could facilitate translation of c-Myc inhibitors into the clinic.
DOI: 10.1371/journal.pone.0055104
发表时间: 2013
期刊: PloS one
影响因子: 3.7
作者:
Bidwell GL 3rd;Perkins E;Hughes J;Khan M;James JR;Raucher D
通讯作者: Raucher D
DOI: 10.1038/s41580-020-0215-2
发表时间: 2020-05
期刊: Nature reviews. Molecular cell biology
影响因子: --
作者:
Baluapuri A;Wolf E;Eilers M
通讯作者: Eilers M
DOI: 10.1038/s41598-018-28107-4
发表时间: 2018-07-03
期刊: Scientific reports
影响因子: 4.6
作者:
Castell A;Yan Q;Fawkner K;Hydbring P;Zhang F;Verschut V;Franco M;Zakaria SM;Bazzar W;Goodwin J;Zinzalla G;Larsson LG
通讯作者: Larsson LG
DOI: 10.1073/pnas.1303002110
发表时间: 2013-09-03
影响因子: 11.1
作者:
Chang, Yong S.;Graves, Bradford;Sawyer, Tomi K.
通讯作者: Sawyer, Tomi K.
DOI: 10.2174/1568009618666180905100608
发表时间: 2019-01-01
影响因子: 3
作者:
Aksoz, Merve;Albayrak, Esra;Kocabas, Fatih
通讯作者: Kocabas, Fatih